Blood News and Research

RSS

Cytogen issued new patent covering oral drug delivery agents

Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors.

28 Nov 2006

Poor memory and slow reactions linked to heart attacks

According to British research, people with a below average mental agility are prone to heart attacks.

27 Nov 2006

Folic acid shown to prevent heart attacks and stroke

British researchers have found enough scientific evidence to support the claim that folic acid is both an easy and inexpensive way to reduce heart disease and strokes.

27 Nov 2006

Man sent to prison for knowingly spreading HIV

A man in the U.S. infected with HIV, who knowingly exposed three women to the virus, has been sentenced to almost three years in prison.

27 Nov 2006

Number of reported HIV/AIDS cases in China increased 28% in 2006

The number of reported HIV/AIDS cases in China increased by 28% in the first 10 months of 2006, and the virus appears to be spreading to a broader population, China's Ministry of Health said Wednesday in a report posted on its Web site, Reuters reports.

23 Nov 2006

VNUS Medical Technologies announces favorable ruling in patent case

VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").

23 Nov 2006

No good reason to invest in new fetal oxygen monitor

New technology for measuring blood oxygen levels of a baby during labor which was intended to provide information useful for preventing birth complications, apparently offers no apparent benefit.

23 Nov 2006

Whoever said people were much the same was wrong!

An international research team have come up with a new genetic map which could demand a fundamental shift in how we think genes work.

22 Nov 2006

BACE 1 gene may hold the key to Alzheimer's

Canadian scientists have found a specific gene which they believe may hold the key to the degenerative brain disorder Alzheimer's disease.

21 Nov 2006

Test strips for the rapid detection of cocaine

Saving the life of a poisoning victim is often a matter of minutes. It is best when the emergency doctor can perform a reliable diagnosis on the spot to determine which poison or what type of drug overdose a patient is suffering from. Complicated laboratory analyses and a complex apparatus are out of place in the emergency room.

21 Nov 2006

Army docs use of dangerous drug labelled irresponsible and inappropriate

American soldiers critically wounded in Iraq are being treated with a potent, experimental, blood-coagulating drug despite evidence it can cause clots in the lungs, heart and brain, leading to strokes, heart attacks and death.

20 Nov 2006

Nanotechnology continues to advance anticancer gene therapy

Given that cancer is a disease in which genetic errors play a major role, it should come as no surprise that many experts envision a time when gene therapy will play an equally important role in the treatment of cancer.

20 Nov 2006

Low-field magnetic separation of monodisperse Fe3O4 nanocrystals

Whether the goal is to separate different types of cells or molecules, methods that rely on the age-old principle of magnetism are a staple among researchers.

20 Nov 2006

Watching a tumor cell migrate

Using a microfluidics device designed to reproduce the physical microenvironment of small blood vessels and the spaces between cells, researchers at the National University of Singapore have imaged single tumor cells deforming as they migrate through the device.

20 Nov 2006

Cancer Research Technology and University of Manchester announce collaboration in oncology with AstraZeneca

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, and The University of Manchester have entered into an agreement with AstraZeneca to establish a clinical pharmacology biomarker research and discovery collaboration.

20 Nov 2006

Combination of depression, anxiety, hostility and anger increases risk for heart disease

Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.

20 Nov 2006

Adolescent girls who live near parks more physically active

Adolescent girls who live within half a mile of a public park are significantly more physically active than other girls, University of North Carolina at Chapel Hill researchers have found.

20 Nov 2006

Cause of exercise intolerance in heart failure patients

A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center.

19 Nov 2006

Evolution is driving therapeutic resistance to cancer therapies

The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.

19 Nov 2006

FDA expands use of Herceptin

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

19 Nov 2006